Progyny, Inc. Common Stock (PGNY) is a publicly traded Healthcare sector company. As of July 16, 2026, PGNY trades at $32.34 with a market cap of $2.53B and a P/E ratio of 39.58. PGNY moved -1.42% today. Year to date, PGNY is +24.07%; over the trailing twelve months it is +38.40%. Its 52-week range spans $13.86 to $33.07. Analyst consensus is strong buy with an average price target of $29.88. Rallies surfaces PGNY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for PGNY, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $32.34 |
| Market Cap | $2.53B |
| P/E Ratio | 39.58 |
| EPS | $0.81 |
| Dividend Yield | 0.00% |
| 52-Week High | $33.07 |
| 52-Week Low | $13.86 |
| Volume | 1.19M |
| Avg Volume | 0 |
| Revenue (TTM) | $1.29B |
| Net Income | $67.69M |
| Gross Margin | 24.11% |
8 analysts cover PGNY: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $29.88.